These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 22187350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
    Lorente L, Lecuona M, Jiménez A, Raja L, Cabrera J, Gonzalez O, Diosdado S, Marca L, Mora ML.
    Am J Infect Control; 2016 Jan 01; 44(1):50-3. PubMed ID: 26412482
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
    Lorente L, Lecuona M, Jiménez A, Lorenzo L, Santacreu R, Ramos S, Hurtado E, Buitrago M, Mora ML.
    Am J Infect Control; 2015 Jul 01; 43(7):711-4. PubMed ID: 25934065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
    Gilbert R, Brown M, Rainford N, Donohue C, Fraser C, Sinha A, Dorling J, Gray J, McGuire W, Gamble C, Oddie SJ, PREVAIL trial team.
    Lancet Child Adolesc Health; 2019 Jun 01; 3(6):381-390. PubMed ID: 31040096
    [Abstract] [Full Text] [Related]

  • 11. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
    Friedman BC, Mian MA, Mullins RF, Hassan Z, Shaver JR, Johnston KK.
    J Burn Care Res; 2015 Jun 01; 36(4):493-9. PubMed ID: 25407386
    [Abstract] [Full Text] [Related]

  • 12. Influence of tracheostomy on the incidence of catheter-related bloodstream infection in the catheterization of jugular vein by posterior access.
    Lorente L, Jiménez A, Roca I, Martín MM, Mora ML.
    Eur J Clin Microbiol Infect Dis; 2011 Sep 01; 30(9):1049-51. PubMed ID: 21301912
    [Abstract] [Full Text] [Related]

  • 13. Risk Factors of Central Venous Catheter-Related Bloodstream Infection for Continuous Renal Replacement Therapy in Kidney Intensive Care Unit Patients.
    Cheng S, Xu S, Guo J, He Q, Li A, Huang L, Liu Z, Li S.
    Blood Purif; 2019 Sep 01; 48(2):175-182. PubMed ID: 30485840
    [Abstract] [Full Text] [Related]

  • 14. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
    Antonelli M, De Pascale G, Ranieri VM, Pelaia P, Tufano R, Piazza O, Zangrillo A, Ferrario A, De Gaetano A, Guaglianone E, Donelli G.
    J Hosp Infect; 2012 Oct 01; 82(2):101-7. PubMed ID: 22938728
    [Abstract] [Full Text] [Related]

  • 15. New choices for central venous catheters: potential financial implications.
    Shorr AF, Humphreys CW, Helman DL.
    Chest; 2003 Jul 01; 124(1):275-84. PubMed ID: 12853534
    [Abstract] [Full Text] [Related]

  • 16. Lower incidence of catheter-related bloodstream infection in subclavian venous access in the presence of tracheostomy than in femoral venous access: prospective observational study.
    Lorente L, Jiménez A, Martín MM, Palmero S, Jiménez JJ, Mora ML.
    Clin Microbiol Infect; 2011 Jun 01; 17(6):870-2. PubMed ID: 21682804
    [Abstract] [Full Text] [Related]

  • 17. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
    Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, Dündar Y, Gamble C, McLeod C, Walley T, Dickson R.
    Health Technol Assess; 2008 Apr 01; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
    [Abstract] [Full Text] [Related]

  • 18. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
    Yücel N, Lefering R, Maegele M, Max M, Rossaint R, Koch A, Schwarz R, Korenkov M, Beuth J, Bach A, Schierholz J, Pulverer G, Neugebauer EA.
    J Antimicrob Chemother; 2004 Dec 01; 54(6):1109-15. PubMed ID: 15537696
    [Abstract] [Full Text] [Related]

  • 19. Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
    Hentrich M, Böll B, Teschner D, Panse J, Schmitt T, Naendrup JH, Schmidt-Hieber M, Neitz J, Fiegle E, Schalk E.
    Infection; 2023 Aug 01; 51(4):1153-1159. PubMed ID: 37016194
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K, Lathyris D, Clouva-Molyvdas P, Haidich AB, Mouloudi E, Synnefaki E, Koulourida V, Georgopoulos D, Gerogianni N, Nakos G, Matamis D, Catheter-Related Infections in ICU (CRI-ICU) Group.
    Crit Care Med; 2012 Feb 01; 40(2):420-9. PubMed ID: 21926583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.